Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Valganciclovir hydrochloride
Drug ID BADD_D02327
Description Valganciclovir hydrochloride (Valcyte, manufactured by Roche) is an antiviral medication used to treat cytomegalovirus infections. As the L-valyl ester of ganciclovir, it is actually a prodrug for ganciclovir. After oral administration, it is rapidly converted to ganciclovir by intestinal and hepatic esterases.
Indications and Usage Valganciclovir is an antiviral medication used for the treatment of cytomegalovirus infections.
Marketing Status Prescription
ATC Code J05AB14
DrugBank ID DB01610
KEGG ID D03256
MeSH ID D000077562
PubChem ID 135413534
TTD Drug ID D06GWF
NDC Product Code 63629-2288; 0603-6330; 69875-8044; 17337-0040; 61876-0072; 0004-0039; 65862-756; 42291-875; 63285-852; 65862-753; 65015-818; 65977-0070; 27241-159; 43598-356; 71666-008; 12869-038; 63739-357; 65015-798; 0591-2579; 55111-929; 55111-884; 38779-3065
Synonyms Valganciclovir | Ganciclovir L-valyl Ester | Ganciclovir L valyl Ester | Valcyt | Valganciclovir Hydrochloride | Valcyte
Chemical Information
Molecular Formula C14H23ClN6O5
CAS Registry Number 175865-59-5
SMILES CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Acne23.02.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Anaemia01.03.02.001--
Aplastic anaemia01.03.03.002--Not Available
Arthralgia15.01.02.001--
Ascites09.01.05.003; 07.07.01.001; 02.05.04.002--
Asthenia08.01.01.001--Not Available
Back pain15.03.04.005--
Blood creatine increased13.13.01.001--Not Available
Carnitine decreased13.12.02.003--Not Available
Confusional state19.13.01.001; 17.02.03.005--
Constipation07.02.02.001--
Cough22.02.03.001--
Dehydration14.05.05.001--
Depression19.15.01.001--
Dermatitis23.03.04.002--Not Available
Diarrhoea07.02.01.001--
Dizziness24.06.02.007; 17.02.05.003; 02.01.02.004--
Dyspepsia07.01.02.001--
Dyspnoea22.02.01.004; 02.01.03.002--
Dysuria20.02.02.002--
Fatigue08.01.01.002--
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hyperkalaemia14.05.03.001--
Hypersensitivity10.01.03.003--
The 1th Page    1 2 3    Next   Last    Total 3 Pages